These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 29432787)

  • 1. Possible involvement of monoamine neurons in the emotional abnormality in Kir6.2-deficient mice.
    Saito A; Miyagawa K; Miyagishi H; Kurokawa K; Umeda A; Okada Y; Tsuji M; Takeda H
    Physiol Behav; 2018 May; 188():251-261. PubMed ID: 29432787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose transporters expression and spatial learning in the K-ATP Kir6.2(-/-) knockout mice.
    Choeiri C; Staines WA; Miki T; Seino S; Renaud JM; Teutenberg K; Messier C
    Behav Brain Res; 2006 Sep; 172(2):233-9. PubMed ID: 16797737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pore-forming subunits of K-ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain.
    Thomzig A; Laube G; Prüss H; Veh RW
    J Comp Neurol; 2005 Apr; 484(3):313-30. PubMed ID: 15739238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2.
    Deacon RM; Brook RC; Meyer D; Haeckel O; Ashcroft FM; Miki T; Seino S; Liss B
    Physiol Behav; 2006 Apr; 87(4):723-33. PubMed ID: 16530794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
    Li CG; Cui WY; Wang H
    Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons.
    Liss B; Bruns R; Roeper J
    EMBO J; 1999 Feb; 18(4):833-46. PubMed ID: 10022826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene targeting approach to clarification of ion channel function: studies of Kir6.x null mice.
    Seino S; Miki T
    J Physiol; 2004 Jan; 554(Pt 2):295-300. PubMed ID: 12826653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation causing increased KATP channel activity leads to reduced anxiety in mice.
    Lahmann C; Clark RH; Iberl M; Ashcroft FM
    Physiol Behav; 2014 Apr; 129():79-84. PubMed ID: 24582665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes.
    Mele A; Camerino GM; Calzolaro S; Cannone M; Conte D; Tricarico D
    Biochem Pharmacol; 2014 Sep; 91(2):266-75. PubMed ID: 24998494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
    Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
    Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
    Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel.
    Reimann F; Proks P; Ashcroft FM
    Br J Pharmacol; 2001 Apr; 132(7):1542-8. PubMed ID: 11264248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K ATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits.
    Yoshida H; Feig JE; Morrissey A; Ghiu IA; Artman M; Coetzee WA
    J Mol Cell Cardiol; 2004 Oct; 37(4):857-69. PubMed ID: 15380676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
    Fang K; Csanády L; Chan KW
    J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.
    Hu X; Xu X; Huang Y; Fassett J; Flagg TP; Zhang Y; Nichols CG; Bache RJ; Chen Y
    Circ Res; 2008 Oct; 103(9):1009-17. PubMed ID: 18802029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
    Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
    Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ZD0947, a novel and potent ATP-sensitive K
    Mori K; Yamashita Y; Teramoto N
    Eur J Pharmacol; 2016 Nov; 791():773-779. PubMed ID: 27693800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.
    Tammaro P; Ashcroft FM
    J Physiol; 2007 Nov; 584(Pt 3):743-53. PubMed ID: 17855752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.